Next generation weight loss drugs are prohibitively expensive for many in the US who would benefit from taking them—and may remain so, thanks to the phenomenon of patent thickets. Paige Huffman ...

Telehealth companies are aggressively marketing GLP-1s as cosmetic elixirs for anyone who wants to lose a few pounds.

Tan France opens up about 'Queer Eye's final season and his work with Zepbound, focusing on compassion, identity, and clothing without shame.

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Eli Lilly stock soars on obesity drug success. See here to know why LLY remains a top pick with strong growth prospects and a ...

The demand for weight-loss drugs like Ozempic and Zepbound is higher than ever, so much so that drugmakers Novo Nordisk and Eli Lilly are planning huge expansions in central North Carolina to meet the ...

Eli Lilly has officially entered the elite $1 trillion market-value club, becoming the first pharmaceutical company to reach ...

(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club ...

The Indianapolis drug giant's stock (LLY) reached an intraday high of $1,061.17 in morning trading and closed at $1,059.70 on Friday, which was above the threshold of $1,057.78 needed for Lilly to ...

Eli Lilly has become the first healthcare company to hit a $1 trillion market value, entering an exclusive club dominated by ...